Veristat is passionate about helping biopharmaceutical innovators to accelerate their rare disease therapies for unmet medical needs through the clinical developmentandregulatory submissionprocess. Veristat ensures that your clinical trial or program design supports your regulatory strategy, disease progression analytical models or previous adult trials. Our experts can help you explore and simulate adaptive trial designs. Then, we find, recruit and engage the patients and sites through to study completion. Lastly, we analyze the data and prepare your submission for regulatory agency review. Veristat is proud to have worked on over 300 rare and ultra- rare disease treatments to date.